Prevalence of chronic complications in Korean patients with type 2 diabetes mellitus based on the korean national diabetes program

Diabetes and Metabolism Journal

Volumn 35, Issue 5, 2011, Pages 504-512

  Rhee, Sang Youl ^a,b   Chon, Suk ^a,b   Kwon, Mi Kwang ^a,b   Park, Ie Byung ^c   Ahn, Kyu Jeung ^a,b   Kim, In Ju ^d   Kim, Sung Hoon ^e   Lee, Hyoung Woo ^f   Koh, Kyung Soo ^g   Kim, Doo Man ^h   Baik, Sei Hyun ⁱ   Lee, Kwan Woo ^j   Nam, Moon Suk ^k   Park, Yong Soo ^l   Woo, Jeong Taek ^a,b   Kim, Young Seol ^a,b  

^a Kyung Hee University Hospital   (South Korea)

^b Kyung Hee University   (South Korea)

^c Gachon University   (South Korea)

^d Pusan National University School of Medicine   (South Korea)

^e Kwandong University College of Medicine   (South Korea)

^f Yeungnam University College of Medicine   (South Korea)

^g Inje University College of Medicine   (South Korea)

^h Hallym University College of Medicine   (South Korea)

ⁱ Korea University College of Medicine   (South Korea)

^j Ajou University School of Medicine   (South Korea)

^k Inha University School of Medicine   (South Korea)

^l Hanyang University College of Medicine   (South Korea)

more..

Author keywords

Cerebrovascular disorders; Coronary disease; Diabetes mellitus; Diabetic retinopathy; Korea; Type 2

Indexed keywords

EID: 84864825217     PISSN: 22336079     EISSN: 22336087     Source Type: Journal    
DOI: 10.4093/dmj.2011.35.5.504     Document Type: Article

References (25)

1. Kasper DL, Harrison TR. Harrison's principles of internal medicine. 16th ed. New York: McGraw-Hill; 2005.
2. Pickup JC, Williams G. Textbook of diabetes. 3rd ed. Malden: Blackwell Science; 2003.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837-53.
5. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10- year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89.
6. ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.
7. Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet 2010;375:408-18.
8. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, Ko SH, Zimmet P, Son HY. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006;368:1681-8.
9. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129-40.
10. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004;27 Suppl 1:S5-10.
11. Teutsch SM, Churchill RE. Principles and practice of public health surveillance. 2nd ed. New York: Oxford University Press; 2000.
12. Ahn YO, Yoo KY, Park BJ, Kim DH, Bae JM, Kang DH, Shin MH, Lee MS. Epidemiology: the principles and applications. 2nd ed. Seoul: Seoul National University Press; 2005.
13. Liebl A, Neiss A, Spannheimer A, Reitberger U, Wieseler B, Stammer H, Goertz A. Complications, co-morbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany-results from the CODE-2 study. Exp Clin Endocrinol Diabetes 2002;110:10-6.
14. Van Acker K, Weyler J, De Leeuw I. The Diabetic Foot Project of Flanders, the northern part of Belgium: implementation of the St Vincent consensus. Sensibilisation and registration in diabetes centres. Acta Clin Belg 2001;56:21-31.
15. Le Floch JP, Thervet F, Desriac I, Boyer JF, Simon D. Management of diabetic patients by general practitioners in France 1997: an epidemiological study. Diabetes Metab 2000;26:43-9.
16. Lundman B, Engstrom L. Diabetes and it's complications in a Swedish county. Diabetes Res Clin Pract 1998;39:157-64.
17. Detournay B, Cros S, Charbonnel B, Grimaldi A, Liard F, Cogneau J, Fagnani F, Eschwege E. Managing type 2 diabetes in France: the ECODIA survey. Diabetes Metab 2000;26:363-9.
18. Henricsson M, Nilsson A, Groop L, Heijl A, Janzon L. Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic control. Acta Ophthalmol Scand 1996;74:523-7.
19. Thai Multicenter Research Group on Diabetes Mellitus. Vascular complications in non-insulin dependent diabetics in Thailand. Diabetes Res Clin Pract 1994;25:61-9.
20. Chuang LM, Tsai ST, Huang BY, Tai TY; Diabcare-Asia 1998 Study Group. The status of diabetes control in Asia-a cross-sectional survey of 24317 patients with diabetes mellitus in 1998. Diabet Med 2002;19:978-85.
21. Tseng CH, Chong CK, Sheu JJ, Wu TH, Tseng CP. Prevalence and risk factors for stroke in type 2 diabetic patients in Taiwan: a cross-sectional survey of a national sample by telephone interview. Diabet Med 2005;22:477-82.
22. Kuzuya T, Akanuma Y, Akazawa Y, Uehata T. Prevalence of chronic complications in Japanese diabetic patients. Diabetes Res Clin Pract 1994;24 Suppl:S159-64.
23. Lee KU, Park JY, Kim SW, Lee MH, Kim GS, Park SK, Park JS. Prevalence and associated features of albuminuria in Koreans with NIDDM. Diabetes Care 1995;18:793-9.
24. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
25. Diamond J. The double puzzle of diabetes. Nature 2003;423: 599-602.